Two functionally active autoantibodies, that were seen in almost all investigated former COVID-19 patients, were directed against the β2-adrenoceptor (β2-fAAB) and the muscarinic M2 receptor (M2-fAAB). The gene discussed is CHRM2; the disease is COVID-19.